MiyauchiA, ItoY, FujishimaM, et al.Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid., 2023; 33(7):817–825; doi: 10.1089/thy.2023.0076.
2.
TuttleRM, FaginJA, MinkowitzG, et al.Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg, 2017; 143:1015–1020; doi: 10.1001/jamaoto.2017.1442.
3.
MolinaroE, CampopianoMC, PieruzziL, et al.Active surveillance in papillary thyroid microcarcinomas is feasible and safe: Experience at a single Italian center. J Clin Endocrinol Metab., 2020; 105(3):e172–e180; doi: 10.1210/clinem/dgz113.
4.
SmuleverA, PitoiaF. Conservative management of low-risk papillary thyroid carcinoma: A review of the active surveillance experience. Thyroid Res, 2023; 16(1):6; doi: 10.1186/s13044-023-00148-6.
5.
SawkaAM, GhaiS, TomlinsonG, et al.A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer. BMJ Open, 2018; 8(4):e020298; doi:10.1136/bmjopen-2017-020298.
6.
KoshkinaA, FazelzadR, SugitaniI, et al.Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg, 2020; 146(6):552–560; doi: 10.1001/jamaoto.2020.0368.
7.
ItoY, MiyauchiA, KiharaM, et al.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 2014; 24(1):27–34; doi: 10.1089/thy.2013.0367
8.
LeeEK, MoonJH, HwangboY, et al.Progression of low-risk papillary thyroid microcarcinoma during active surveillance: Interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea. Thyroid., 2022; 32(11):1328–1336; doi: 10.1089/thy.2021.0614.
9.
YamamotoM, MiyauchiA, ItoY, FujishimaM, SasakiT, KudoT. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance. Surgery, 2024; 175(4):1089–1094; doi: 10.1016/j.surg.2023.11.022.
10.
SawkaAM, GhaiS, RotsteinL, et al.Long-term durability of active surveillance of small, low-risk papillary thyroid cancer. JAMA Surg, 2025; 160(10):1117–1124; doi: 10.1001/jamasurg.2025.2957.
